Breast Cancer Clinical Trials
Find clinical trials for breast cancer. Search for breast cancer clinical trials in different cities and states across the United States.
Doxorubicin Hydrochloride Liposome in Treating Women With Ductal Carcinoma in Situ Undergoing SurgeryDoxorubicin Hydrochloride Liposome in Treating Women With Ductal Carcinoma in Situ Undergoing Surgery
Sponsor:
Dr. Susan Love Research Foundation
Location:
Code:
NCT00671476
Conditions
Breast Cancer
Eligibility Criteria
Sex: Female
Age: 18+
Healthy Volunteers: Not accepted
Interventions
pegylated liposomal doxorubicin hydrochloride
DNA methylation analysis
TdT-mediated dUTP nick end labeling assay
fluorescence in situ hybridization
loss of heterozygosity analysis
Comparing Supplemental Topical Agents for the Treatment of Acute Radiation Dermatitis in Patients With Breast CancerComparing Supplemental Topical Agents for the Treatment of Acute Radiation Dermatitis in Patients With Breast Cancer
Sponsor:
City of Hope Medical Center
Location:
Code:
NCT05340673
Conditions
Breast Ductal Carcinoma In Situ
Invasive Breast Carcinoma
Eligibility Criteria
Sex: Female
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Agent Affecting Integumentary System
Petrolatum-Mineral Oil-Lanolin-Ceresin Ointment
Quality-of-Life Assessment
Questionnaire Administration
A Study of Blood Pressure Control During Cancer TreatmentA Study of Blood Pressure Control During Cancer Treatment
Sponsor:
Memorial Sloan Kettering Cancer Center
Location:
Code:
NCT06023576
Conditions
Breast Cancer
Cardiotoxicity
Eligibility Criteria
Sex: Female
Age: 18+
Healthy Volunteers: Not accepted
Interventions
antihypertensive medications
Blood pressure measurement
Echocardiogram
Symptom-limited cardiopulmonary exercise test
Quality of Life Measures
Breast Cancer Pre-habilitation and Prospective Surveillance to Prevent, Detect, and Optimize Physical and FunctionBreast Cancer Pre-habilitation and Prospective Surveillance to Prevent, Detect, and Optimize Physical and Function
Sponsor:
Northwestern University
Location:
Code:
NCT06081127
Conditions
Breast Cancer
Eligibility Criteria
Sex: Female
Age: 18+
Healthy Volunteers: Not accepted
Interventions
MOve-ABC
Enhanced Usual Care
SEroma Reduction pOst MAstectomy "SEROMA Study"SEroma Reduction pOst MAstectomy "SEROMA Study"
Sponsor:
Hamilton Health Sciences Corporation
Location:
Code:
NCT03738527
Conditions
Seroma Complicating A Procedure
Hematoma Postoperative
Breast Cancer
Eligibility Criteria
Sex: Female
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Tranexamic Acid 100mg/mL, 20mL topical
Normal Saline Flush, 0.9%, 20mL topical
PHESGO Maintenance After T-DXd Short Induction for HER2+ Unresectable Locally Recurrent or Metastatic Breast CancerPHESGO Maintenance After T-DXd Short Induction for HER2+ Unresectable Locally Recurrent or Metastatic Breast Cancer
Sponsor:
MedSIR
Location:
Code:
NCT06172127
Conditions
HER2-positive Breast Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Trastuzumab deruxtecan
Phesgo 1,200 MG / 600 MG / 30,000 UNT Per 15 ML Injection
Phesgo 600 MG / 600 MG / 20,000 UNT in 10 mL Injection
Intraoperative Use of ClearEdge Device in Breast Conserving SurgeryIntraoperative Use of ClearEdge Device in Breast Conserving Surgery
Sponsor:
LS BioPath
Location:
Code:
NCT05456373
Conditions
Breast Cancer
Eligibility Criteria
Sex: Female
Age: 18+
Healthy Volunteers: Not accepted
Interventions
ClearEdge device
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
Sponsor:
Merck Sharp & Dohme LLC
Location:
Code:
NCT06312176
Conditions
Breast Neoplasms
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Sacituzumab tirumotecan
Pembrolizumab
Paclitaxel
Nab-paclitaxel
Capecitabine
Registry of Patients Undergoing Cryoablation for Early Stage Breast CancerRegistry of Patients Undergoing Cryoablation for Early Stage Breast Cancer
Sponsor:
Jonsson Comprehensive Cancer Center
Location:
Code:
NCT06387173
Conditions
Early Stage Breast Carcinoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Non-Interventional Study
F-Tryptophan PET/CT in Human CancersF-Tryptophan PET/CT in Human Cancers
Sponsor:
Barbara Ann Karmanos Cancer Institute
Location:
Code:
NCT05556473
Conditions
Intracranial Glioma
Metastatic Brain Tumor
Breast Cancer
Neuroendocrine Tumors
Rectal Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
1-(2-[18F]FLUOROETHYL)-L-Tryptophan